XML 81 R54.htm IDEA: XBRL DOCUMENT v3.25.2
Shareholders' Deficit (Details)
12 Months Ended
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2025
€ / shares
Jun. 30, 2024
€ / shares
May 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Common Stock, Shares, Outstanding 24,477,325 25,080,022        
Share-based compensation expense | $ $ 58,879,000 $ 65,584,000 $ 42,122,000      
Issuance of ordinary shares due to share option exercises, Shares (29,784)          
Share-based Payment Arrangement, Amount Capitalized | $ $ 3,808,000 $ 3,160,000 1,879,000      
Common Stock, Capital Shares Reserved for Future Issuance 2,211,747          
Stock Repurchased During Period, Shares 316,056 300,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 287,907 338,593        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares $ 46.20          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares $ 45.96 $ 46.39        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 7 years          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 200,106,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares $ 46.11          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 7 years 3 months 18 days        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ $ 1,318,000 $ 1,816,000 $ 275,000      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares   $ 109.48        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 80.80          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number   1,934,853        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (29,784)          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ / shares $ 52.56          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares (20,902)          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 1,055,377          
Class of Warrant or Right, Percentage of Securities           3.875%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 60          
Warrants Not Settleable in Cash, Fair Value Disclosure | $ $ 22,432,000          
Common Stock, Value per Share | € / shares       € 0.01 € 0.01  
Common Stock, Discount on Shares | $ 1.78 $ 2.14        
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ $ 68,370,000          
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 9 months 18 days          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     3.06%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend     0.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term     4 years 3 days      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate     61.99%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares     $ 22.83      
Shareholders' Equity and Share-based Payments 1,318          
Preferred Units, Authorized 276          
Share-Based Payment Arrangement, Expense | $ $ 4,800,000          
Share-Based Payment Arrangement, Exercise of Option, Tax Benefit | $ 10,797,000 11,970,000 $ 7,649,000      
2020 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-Based Payment Arrangement, Exercise of Option, Tax Benefit | $ 426,000 $ 1,190,000 $ (2,514,000)      
Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 71.42 $ 44.25      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $ $ 38,110,000 $ 47,661,000 $ 13,544,000      
Restricted share units [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares $ 69.89 $ 62.59        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 377,492          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 83.71          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (538,975)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 65.61          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (76,349)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 865,881 1,103,713        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares $ 62.84          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $ $ 40,696,000          
2020 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ $ 344,000 $ 13,956,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $   $ 1,816,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares $ 106.93          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 685,291          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 70.21 $ 17.61      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,260,459          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (324,909)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 70.22          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (34,776)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $ $ 106,242,000 $ 169,512,000 $ 83,376,000      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ $ 223,000          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares $ 76.51          
Shareholders' Equity and Share-based Payments     41      
Maximum [Member] | 2020 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares Authorized for Grants 7,500,000          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 250.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 4,623,522          
Minimum [Member] | 2020 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 0.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 685,084